Anuh Pharma is currently trading at Rs. 153.00, up by 15.10 points or 10.95% from its previous closing of Rs. 137.90 on the BSE.
The scrip opened at Rs. 142.85 and has touched a high and low of Rs. 155.00 and Rs. 138.05 respectively. So far 6089 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 173.00 on 14-Nov-2018 and a 52 week low of Rs. 101.25 on 02-Aug-2019.
Last one week high and low of the scrip stood at Rs. 158.90 and Rs. 137.10 respectively. The current market cap of the company is Rs. 368.32 crore.
The promoters holding in the company stood at 71.78%, while Non-Institutions held 28.22% stake in the company.
The US Food and Drug Administration (USFDA) has successfully completed an inspection at Anuh Pharma’s facility. The facility was inspected by USFDA from September 16, 2019 to September 20, 2019. At the end of the inspection, no observation (483) was issued.
Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1620.50 |
Dr. Reddys Lab | 6171.85 |
Cipla | 1494.65 |
Zydus Lifesciences | 1013.75 |
Lupin | 1617.85 |
View more.. |